Plasma Medicine: A Field of Applied Redox Biology.


Journal

In vivo (Athens, Greece)
ISSN: 1791-7549
Titre abrégé: In Vivo
Pays: Greece
ID NLM: 8806809

Informations de publication

Date de publication:
Historique:
received: 07 03 2019
revised: 18 04 2019
accepted: 24 04 2019
entrez: 8 7 2019
pubmed: 8 7 2019
medline: 21 12 2019
Statut: ppublish

Résumé

Plasma medicine comprises the application of physical plasma directly on or in the human body for therapeutic purposes. Three most important basic plasma effects are relevant for medical applications: i) inactivation of a broad spectrum of microorganisms, including multidrug-resistant pathogens, ii) stimulation of cell proliferation and angiogenesis with lower plasma treatment intensity, and iii) inactivation of cells by initialization of cell death with higher plasma treatment intensity, above all in cancer cells. Based on own published results as well as on monitoring of relevant literature the aim of this topical review is to summarize the state of the art in plasma medicine and connect it to redox biology. One of the most important results of basic research in plasma medicine is the insight that biological plasma effects are mainly mediated via reactive oxygen and nitrogen species influencing cellular redox-regulated processes. Plasma medicine can be considered a field of applied redox biology.

Identifiants

pubmed: 31280189
pii: 33/4/1011
doi: 10.21873/invivo.11570
pmc: PMC6689367
doi:

Substances chimiques

Plasma Gases 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1011-1026

Informations de copyright

Copyright© 2019, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Références

Int J Pharm. 2001 Sep 11;226(1-2):1-21
pubmed: 11532565
Annu Rev Pharmacol Toxicol. 2003;43:175-97
pubmed: 12195028
Photochem Photobiol Sci. 2002 Apr;1(4):225-36
pubmed: 12661961
Science. 2003 Oct 17;302(5644):376-9
pubmed: 14563981
Mol Cell Biol. 2004 Jan;24(1):36-45
pubmed: 14673141
Physiol Rev. 2005 Jul;85(3):943-78
pubmed: 15987799
Rev Gastroenterol Disord. 2006 Winter;6(1):1-12
pubmed: 16520707
Toxicol Appl Pharmacol. 2007 Jul 1;222(1):122-8
pubmed: 17459441
Biochim Biophys Acta. 2008 Nov;1780(11):1348-61
pubmed: 18249195
J Cosmet Dermatol. 2008 Sep;7(3):169-79
pubmed: 18789051
Nat Rev Drug Discov. 2009 Jul;8(7):579-91
pubmed: 19478820
Biomacromolecules. 2009 Sep 14;10(9):2351-78
pubmed: 19655722
Ann Biomed Eng. 2010 Mar;38(3):748-57
pubmed: 20013154
GMS Krankenhhyg Interdiszip. 2008 Nov 03;3(1):Doc13
pubmed: 20204115
Br J Dermatol. 2010 Jul;163(1):78-82
pubmed: 20222930
J Eur Acad Dermatol Venereol. 2011 Jan;25(1):1-11
pubmed: 20497290
Acta Biomater. 2011 May;7(5):2015-28
pubmed: 21194574
PLoS One. 2011 Jan 21;6(1):e16270
pubmed: 21283714
Int J Cancer. 2012 May 1;130(9):2185-94
pubmed: 21702038
Proteomics. 2011 Sep;11(17):3518-30
pubmed: 21751354
Br J Cancer. 2011 Oct 25;105(9):1295-301
pubmed: 21979421
J Gerontol A Biol Sci Med Sci. 2012 Aug;67(8):821-9
pubmed: 22219515
Br J Dermatol. 2012 Aug;167(2):404-10
pubmed: 22385038
Facial Plast Surg Clin North Am. 2012 May;20(2):145-62, v-vi
pubmed: 22537783
PLoS One. 2012;7(4):e34610
pubmed: 22558091
Biol Chem. 2012 Sep;393(9):999-1004
pubmed: 22944698
BMC Cancer. 2012 Oct 15;12:473
pubmed: 23066891
Photochem Photobiol Sci. 2013 Jan;12(1):54-64
pubmed: 23111621
Biochem Pharmacol. 2013 Mar 15;85(6):705-17
pubmed: 23219527
Mutat Res. 2013 Apr 30;753(1):23-8
pubmed: 23416235
Arch Med Res. 2013 Apr;44(3):169-77
pubmed: 23506720
J Dermatol Sci. 2013 Jun;70(3):173-81
pubmed: 23619096
Expert Rev Med Devices. 2013 May;10(3):367-77
pubmed: 23668708
Proteomics. 2013 Sep;13(17):2608-21
pubmed: 23794223
Pharmazie. 2013 Jul;68(7):492-8
pubmed: 23923628
Wound Repair Regen. 2013 Nov-Dec;21(6):800-7
pubmed: 23937657
Cell Biol Int. 2014 Apr;38(4):412-25
pubmed: 24155089
PLoS One. 2013 Nov 12;8(11):e79325
pubmed: 24265766
Redox Biol. 2014 Jan 10;2:358-60
pubmed: 24563853
J Eur Acad Dermatol Venereol. 2015 Jan;29(1):148-55
pubmed: 24666170
Transl Vis Sci Technol. 2014 Mar 27;3(2):2
pubmed: 24757592
Nat Rev Mol Cell Biol. 2014 Jun;15(6):411-21
pubmed: 24854789
Antioxid Redox Signal. 2014 Dec 20;21(18):2459-68
pubmed: 25178739
Biomol Ther (Seoul). 2014 Nov;22(6):477-90
pubmed: 25489414
Redox Biol. 2015;4:180-3
pubmed: 25588755
J Biol Chem. 2015 Mar 13;290(11):6731-50
pubmed: 25589789
J Dtsch Dermatol Ges. 2015 Feb;13(2):143-50
pubmed: 25597338
Int J Mol Sci. 2015 Jan 29;16(2):2971-3016
pubmed: 25642755
Biointerphases. 2015 Jun 01;10(2):029506
pubmed: 25832438
Biointerphases. 2015 Jun 06;10(2):029518
pubmed: 25947392
J Wound Care. 2015 May;24(5):196, 198-200, 202-3
pubmed: 25970756
Clin Exp Dermatol. 2016 Mar;41(2):202-9
pubmed: 26175125
J Tissue Eng Regen Med. 2016 Apr;10(4):348-57
pubmed: 26227832
J Nutr Biochem. 2015 Dec;26(12):1401-13
pubmed: 26419687
Biomed Res Int. 2015;2015:506059
pubmed: 26539504
Sci Rep. 2015 Dec 17;5:18339
pubmed: 26677750
Int Wound J. 2017 Feb;14(1):89-96
pubmed: 26688157
Chemistry. 2016 Mar 1;22(10):3496-3505
pubmed: 26833560
Tumour Biol. 2016 Jun;37(6):7021-31
pubmed: 26888782
Sci Rep. 2016 Feb 23;6:19144
pubmed: 26902681
Mutat Res Genet Toxicol Environ Mutagen. 2016 Mar;798-799:48-54
pubmed: 26994493
Clin Plasma Med. 2014 Jul;2(1):4-10
pubmed: 27030818
J Chin Med Assoc. 2016 Jun;79(6):320-8
pubmed: 27036493
Arch Biochem Biophys. 2016 Sep 1;605:3-10
pubmed: 27109191
Nat Commun. 2016 May 23;7:11624
pubmed: 27211851
Eur J Cardiothorac Surg. 2017 Jan;51(1):186-187
pubmed: 27354253
Exp Dermatol. 2017 Feb;26(2):156-162
pubmed: 27492871
J Craniomaxillofac Surg. 2016 Sep;44(9):1445-52
pubmed: 27499516
Int J Low Extrem Wounds. 2016 Dec;15(4):313-319
pubmed: 27581113
PLoS One. 2016 Sep 01;11(9):e0160667
pubmed: 27584003
J Oral Maxillofac Surg. 2017 Feb;75(2):429-435
pubmed: 27637776
Exp Dermatol. 2017 Feb;26(2):163-170
pubmed: 27673439
Sci Rep. 2016 Nov 08;6:36282
pubmed: 27824103
Sci Rep. 2016 Nov 21;6:37338
pubmed: 27869147
Redox Biol. 2017 Apr;11:613-619
pubmed: 28110218
J Appl Microbiol. 2017 Aug;123(2):308-324
pubmed: 28245092
Sci Rep. 2017 Mar 24;7:45183
pubmed: 28338059
Environ Mol Mutagen. 2017 Apr;58(3):172-177
pubmed: 28370324
Int J Mol Sci. 2017 Apr 19;18(4):null
pubmed: 28422070
Plasma Med. 2016;6(2):135-177
pubmed: 28428835
Annu Rev Biochem. 2017 Jun 20;86:715-748
pubmed: 28441057
Redox Biol. 2017 Oct;13:94-162
pubmed: 28577489
Biophys J. 2017 Jun 6;112(11):2397-2407
pubmed: 28591612
J Eur Acad Dermatol Venereol. 2018 Jan;32(1):e37-e39
pubmed: 28695987
Sci Rep. 2017 Jul 18;7(1):5761
pubmed: 28720839
Sci Rep. 2017 Jul 21;7(1):6146
pubmed: 28733577
Sci Rep. 2017 Sep 7;7(1):10831
pubmed: 28883477
Free Radic Biol Med. 2018 Feb 1;115:43-56
pubmed: 29138018
Environ Mol Mutagen. 2018 May;59(4):268-277
pubmed: 29417643
Phys Chem Chem Phys. 2018 Mar 7;20(10):6845-6859
pubmed: 29460930
Am J Ophthalmol. 2018 Jun;190:150-163
pubmed: 29580975
Sci Rep. 2018 Apr 4;8(1):5621
pubmed: 29618775
J Appl Microbiol. 2018 Aug;125(2):398-408
pubmed: 29655267
Trends Biotechnol. 2018 Jun;36(6):627-638
pubmed: 29729997
Anticancer Agents Med Chem. 2018;18(6):824-831
pubmed: 29732979
Sci Rep. 2018 May 16;8(1):7736
pubmed: 29769633
Appl Environ Microbiol. 2018 Aug 17;84(17):
pubmed: 29915117
Ther Adv Med Oncol. 2018 Jul 20;10:1758835918786475
pubmed: 30046358
Antioxidants (Basel). 2018 Oct 19;7(10):null
pubmed: 30347767
Oxid Med Cell Longev. 2019 Jan 13;2019:7017363
pubmed: 30733851
Theranostics. 2019 Jan 30;9(4):1066-1084
pubmed: 30867816
Eur J Biochem. 1993 Jul 15;215(2):213-9
pubmed: 7688300

Auteurs

Thomas VON Woedtke (T)

Leibniz Institute for Plasma Science and Technology, INP Greifswald, Greifswald, Germany woedtke@inp-greifswald.de.
Greifswald University Medicine, Greifswald, Germany.

Anke Schmidt (A)

Leibniz Institute for Plasma Science and Technology, INP Greifswald, Greifswald, Germany.

Sander Bekeschus (S)

ZIK plasmatis at INP Greifswald, Greifswald, Germany.

Kristian Wende (K)

ZIK plasmatis at INP Greifswald, Greifswald, Germany.

Klaus-Dieter Weltmann (KD)

Leibniz Institute for Plasma Science and Technology, INP Greifswald, Greifswald, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH